相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical effects of natalizumab on multiple sclerosis appear early in treatment course
Ludwig Kappos et al.
JOURNAL OF NEUROLOGY (2013)
Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: Illustration over a 20-year period
Stephanie Clisant et al.
CONTEMPORARY CLINICAL TRIALS (2012)
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: A systematic review and meta-analysis
Richard Nicholas et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
The quality of reports of randomized trials in multiple sclerosis: a review
Alessio Signori et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Placebo Cohorts in Phase-3 MS Treatment Trials - Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data
Jan-Patrick Stellmann et al.
PLOS ONE (2012)
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design
Richard Nicholas et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
The changing demographic pattern of multiple sclerosis epidemiology
Nils Koch-Henriksen et al.
LANCET NEUROLOGY (2010)
Assessing changes in relapse rates in multiple sclerosis
Seidu Inusah et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Relapses in multiple sclerosis are age- and time-dependent
H. Tremlett et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Regression to the mean in multiple sclerosis
S. Martinez-Yelamos et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Predictors of relapse rate in MS clinical trials
U Held et al.
NEUROLOGY (2005)
分享论文
